VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Advantech Co., Ltd. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Advantech Co., Ltd.
2395 · Taiwan Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Advantech Co., Ltd.'s moat claims, evidence, and risks.
View 2395 analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 62 / 100 for Advantech Co., Ltd.).
- Segment focus: Advantech Co., Ltd. has 3 segments (49% in Industrial Computer and Industrial Control); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Advantech Co., Ltd. has 5 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Advantech Co., Ltd.
Industrial Computer and Industrial Control
Industrial PCs and industrial control computing (industrial automation, edge industrial computing)
Global
Industrial enterprises, system integrators, and industrial OEMs
Industrial computing OEM + solution integrator
49%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Advantech Co., Ltd. strengths
Sanofi strengths
Segment mix
Advantech Co., Ltd. segments
Full profile >Industrial Computer and Industrial Control
Competitive
Embedded Boards and Chassis
Competitive
After-sales Service and Others
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.